The usual cause for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Qingsong Fund, Milestone Capital China.
The high activity for fund was in 2019. The typical startup value when the investment from Haidu Group is 10-50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 1 - 5 millions dollars.
Among the various public portfolio startups of the fund, we may underline No-Antibiotics Among the most successful fund investment fields, there is Biotechnology.
Fund Name | Location |
Access Technology Partners | Connecticut, Shelton, United States |
Chameleon Invest | Béreldange, Canton Luxembourg, Luxembourg |
China Fortune International Trust | Beijing, Beijing, China |
Cool Japan Fund | Chiyoda, Japan |
Daintree.VC | England, London, United Kingdom |
GCI | United States, Waukesha, Wisconsin |
Gett | England, London, United Kingdom |
HaiKe Zhineng | - |
Innovative Medical Management | Anaheim, California, United States |
ION Crossover Partners | Israel, Tel Aviv, Tel Aviv District |
Lakeland Equity Partners | - |
NKM Capital | New York, New York, United States |
Qianhai Mengchuang Kongjian | China, Guangdong, Shenzhen |
Rampart Capital LLP | England, London, United Kingdom |
Saban Capital Group | California, Los Angeles, United States |
Symphony Technology Group | California, Palo Alto, United States |
TinkBig Venture | Kuala Lumpur, Malaysia |
UFP Fintech | England, London, United Kingdom |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
$3M | 22 May 2019 | Shandong |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
$3M | 22 May 2019 | Shandong |